By Thomas Green On Running (NYSE: ONON) said net sales increased 46.6% in 2023, reaching CHF 1,792.1 million. Increased brand awareness in fourth quarter boosted direct-to-customer sales to 46.2% and helped On achieve a sales growth of over 31% on...

By Karen Roman Conduit Pharmaceuticals Inc. (Nasdaq: CDT), a clinical-stage life science company, reported it has opened a new cutting-edge laboratory space in Cambridge, U.K. This new facility sits within a space of 150 acres and 2 million square feet...

By Karen Roman Gryphon Digital Mining, Inc. (Nasdaq: GRYP), a sustainable bitcoin miner, announced its average self-mining hashing power rose to an all-time high of 911 PH/s in February 2024, increasing 5% monthly with the operation of newer generation S19k...

By Daniella Parra The Duckhorn Portfolio, Inc. (NYSE: NAPA) saw a gross profit of $58.3 million, an increase of $3.1 million, and an adjusted EBITDA of $42.7 million, an increase of $3.9 million for the fiscal second quarter 2024, they...

By Daniella Parra Promontory Therapeutics Inc. completed enrollment of 109 late-stage metastatic castration-resistant prostate cancer patients for its Phase 2 trial of PT-112, which assesses its efficacy in patients who have undergone prior treatments, the company said. PT-112 is a...

By Karen Roman Potbelly Corporation (Nasdaq: PBPB), the neighborhood sandwich shop company originally from Chicago, reported its total revenue grew 4.7% to $125.7 million in the last quarter of 2023, compared to $120.2 million in 2022. Average Weekly Sales (AWS)...

By Daniella Parra Grove Collaborative Holdings, Inc. (NYSE: GROV) reported their Fourth Quarter Adjusted EBITDA of $0.1 million, positive for the second quarter in a row, and a record net revenue per order of $66.83. The sustainable consumer products company...

By Karen Roman a.k.a. Brands Holding Corp. (NYSE: AKA), a company that accelerates next generation fashion brands, announced its U.S. net sales grew 11.6% on the last quarter of 2023 and its total net sales decreased 0.1% to $148.9 million,...

By Daniella Parra Sparrow Pharmaceuticals continues its PROST! Phase 2 clinical trial for treating polymyalgia rheumatica (PMR) with SPI-62 and prednisolone, adding a fourth cohort, they said. PMR, an autoimmune disorder common among the elderly, traditionally treated with steroids like...

By Ambassador Marko Đurić Serbia has undergone a profound transformation over the past decade. Spearheaded by President Aleksandar Vučić’s vision of economic development and propelled by strategic reforms, our country’s economy has been booming as it charts a new course...